{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:27:10Z","timestamp":1793237230259,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","award":["IMRF\/JULY-SEPT 2022-23\/Proposal no 3\/"],"award-info":[{"award-number":["IMRF\/JULY-SEPT 2022-23\/Proposal no 3\/"]}],"id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07508-5","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:03:49Z","timestamp":1762473829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early use of neutral Protamine Hagedorn (NPH) insulin in the management of diabetic ketoacidosis: an open-label randomized controlled trial in a resource-limited setting"],"prefix":"10.1186","volume":"18","author":[{"given":"Naveen","family":"Baby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukta","family":"Wyawahare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dukhabandhu","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishaant","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"7508_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/dom.14929","volume":"25","author":"K Thammakosol","year":"2023","unstructured":"Thammakosol K, Sriphrapradang C. Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial. Diabetes Obes Metab. 2023;25:815\u201322. https:\/\/doi.org\/10.1111\/dom.14929.","journal-title":"Diabetes Obes Metab"},{"key":"7508_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2017.08.025","volume":"47","author":"L Barski","year":"2018","unstructured":"Barski L, Brandstaetter E, Sagy I, Jotkowitz A. Basal insulin for the management of diabetic ketoacidosis. Eur J Intern Med. 2018;47:14\u20136. https:\/\/doi.org\/10.1016\/j.ejim.2017.08.025.","journal-title":"Eur J Intern Med"},{"key":"7508_CR3","doi-asserted-by":"publisher","first-page":"e030221191986","DOI":"10.2174\/1573399817666210303095633","volume":"17","author":"A Mohamed","year":"2021","unstructured":"Mohamed A, Ploetz J, Hamarshi MS. Evaluation of early administration of insulin glargine in the acute management of diabetic ketoacidosis. Curr Diabetes Rev. 2021;17:e030221191986. https:\/\/doi.org\/10.2174\/1573399817666210303095633.","journal-title":"Curr Diabetes Rev"},{"key":"7508_CR4","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00134-007-0674-3","volume":"33","author":"V Shankar","year":"2007","unstructured":"Shankar V, Haque A, Churchwell KB, et al. Insulin glargine supplementation during early management phase of diabetic ketoacidosis in children. Intensive Care Med. 2007;33:1173\u20138. https:\/\/doi.org\/10.1007\/s00134-007-0674-3.","journal-title":"Intensive Care Med"},{"key":"7508_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/acem.12673","volume":"22","author":"P Doshi","year":"2015","unstructured":"Doshi P, Potter AJ, De Los Santos D, Banuelos R, Darger BF, Chathampally Y. Prospective randomized trial of insulin glargine in acute management of diabetic ketoacidosis in the emergency department: A pilot study. Acad Emerg Med. 2015;22:657\u201362. https:\/\/doi.org\/10.1111\/acem.12673.","journal-title":"Acad Emerg Med"},{"key":"7508_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3803\/EnM.2022.1447","volume":"37","author":"Y Lim","year":"2022","unstructured":"Lim Y, Ohn JH, Jeong J, Ryu J, Kim SW, Cho JH, et al. Effect of the concomitant use of subcutaneous basal insulin and intravenous insulin infusion in the treatment of severe hyperglycemic patients. Endocrinol Metab. 2022;37:444\u201354. https:\/\/doi.org\/10.3803\/EnM.2022.1447.","journal-title":"Endocrinol Metab"},{"key":"7508_CR7","doi-asserted-by":"publisher","first-page":"OC01","DOI":"10.7860\/JCDR\/2015\/11920.5632","volume":"9","author":"J Houshyar","year":"2015","unstructured":"Houshyar J, Bahrami A, Aliasgarzadeh A. Effectiveness of insulin glargine on recovery of patients with diabetic ketoacidosis: A randomized controlled trial. J Clin Diagn Res. 2015;9:OC01\u20135. https:\/\/doi.org\/10.7860\/JCDR\/2015\/11920.5632.","journal-title":"J Clin Diagn Res"},{"key":"7508_CR8","doi-asserted-by":"publisher","first-page":"CD005613","DOI":"10.1002\/14651858.CD005613.pub3","volume":"11","author":"T Semlitsch","year":"2020","unstructured":"Semlitsch T, Engler J, Siebenhofer A, Jeitler K, Berghold A, Horvath K. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2020;11:CD005613. https:\/\/doi.org\/10.1002\/14651858.CD005613.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"7508_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1001\/jama.2018.7993","volume":"320","author":"KJ Lipska","year":"2018","unstructured":"Lipska KJ, Parker MM, Moffet HH, Huang ES, Karter AJ. Association of initiation of basal insulin analogs vs neutral Protamine Hagedorn insulin with hypoglycemia-related emergency department visits or hospital admissions and with glycemic control in patients with type 2 diabetes. JAMA. 2018;320:53\u201362. https:\/\/doi.org\/10.1001\/jama.2018.7993.","journal-title":"JAMA"},{"key":"7508_CR10","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1210\/jc.2012-1244","volume":"97","author":"E Hsia","year":"2012","unstructured":"Hsia E, Seggelke S, Gibbs JR, Hawkins M, Cohlmia E, Rasouli N, et al. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab. 2012;97:3132\u20137. https:\/\/doi.org\/10.1210\/jc.2012-1244.","journal-title":"J Clin Endocrinol Metab"},{"key":"7508_CR11","doi-asserted-by":"publisher","first-page":"e14788","DOI":"10.1111\/dme.14788","volume":"39","author":"KK Dhatariya","year":"2022","unstructured":"Dhatariya KK, Joint British Diabetes Societies for Inpatient Care. The management of diabetic ketoacidosis in adults: an updated guideline from the joint British diabetes society for inpatient care. Diabet Med. 2022;39:e14788. https:\/\/doi.org\/10.1111\/dme.14788.","journal-title":"Diabet Med"},{"key":"7508_CR12","first-page":"14","volume":"65","author":"NM Ivers","year":"2019","unstructured":"Ivers NM, Jiang M, Alloo J, Singer A, Ngui D, Casey CG, et al. Diabetes Canada 2018 clinical practice guidelines. Can Fam Physician. 2019;65:14\u201324.","journal-title":"Can Fam Physician"},{"key":"7508_CR13","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2337\/dc09-9032","volume":"32","author":"AE Kitabchi","year":"2009","unstructured":"Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32:1335\u201343. https:\/\/doi.org\/10.2337\/dc09-9032.","journal-title":"Diabetes Care"},{"key":"7508_CR14","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2337\/dci24-0032","volume":"47","author":"GE Umpierrez","year":"2024","unstructured":"Umpierrez GE, Davis GM, ElSayed NA, Fadini GP, Galindo RJ, Hirsch IB, et al. Hyperglycemic crises in adults with diabetes: A consensus report. Diabetes Care. 2024;47:1257\u201375. https:\/\/doi.org\/10.2337\/dci24-0032.","journal-title":"Diabetes Care"},{"key":"7508_CR15","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1097\/MS9.0000000000000894","volume":"85","author":"E Chukwuka","year":"2023","unstructured":"Chukwuka E, Johnson AD, Abasi -OU, Emmanuel OE, Ogbuiyi-Chima IC, Unakalamba LO, et al. Comprehensive review of diabetic ketoacidosis: an update. Ann Med Surg (Lond). 2023;85:2802\u20137. https:\/\/doi.org\/10.1097\/MS9.0000000000000894.","journal-title":"Ann Med Surg (Lond)"},{"key":"7508_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/ijem.IJEM_225_20","volume":"24","author":"R Chawla","year":"2020","unstructured":"Chawla R, Madhu SV, Makkar BM, Ghosh S, Saboo B, Kalra S, et al. RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020. Indian J Endocrinol Metab. 2020;24:1\u2013122. https:\/\/doi.org\/10.4103\/ijem.IJEM_225_20.","journal-title":"Indian J Endocrinol Metab"},{"key":"7508_CR17","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee; 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes\u20142025. Diabetes Care 1. January 2025; 48 (Supplement_1): S181\u2013S206. https:\/\/doi.org\/10.2337\/dc25-S009","DOI":"10.2337\/dc25-S009"},{"key":"7508_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/07853890.2023.2175031","volume":"55","author":"F Ata","year":"2023","unstructured":"Ata F, Khan AA, Khamees I, Iqbal P, Yousaf Z, Mohammed BZM, et al. Clinical and biochemical determinants of length of stay, readmission and recurrence in patients admitted with diabetic ketoacidosis. Ann Med. 2023;55:533\u201342. https:\/\/doi.org\/10.1080\/07853890.2023.2175031.","journal-title":"Ann Med"},{"key":"7508_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/STROKEAHA.121.035301","volume":"53","author":"NAM van der Ende","year":"2022","unstructured":"van der Ende NAM, Roozenbeek B, Berkhemer OA, Koudstaal PJ, Boiten J. MR CLEAN Investigators. Added value of a blinded outcome adjudication committee in an open-label randomized stroke trial. Stroke. 2022;53:61\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.121.035301.","journal-title":"Stroke"},{"key":"7508_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/0141076813485350","volume":"106","author":"A Maru\u0161i\u0107","year":"2013","unstructured":"Maru\u0161i\u0107 A, Feren\u010di\u0107 SF. Adoption of the double dummy trial design to reduce observer bias in testing treatments. J R Soc Med. 2013;106:196\u20138. https:\/\/doi.org\/10.1177\/0141076813485350.","journal-title":"J R Soc Med"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07508-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07508-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07508-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:03:50Z","timestamp":1762473830000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07508-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7508"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07508-5","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institute Ethics Committee at Jawaharlal Institute of Postgraduate Medical Education and Research (Ref No JIP\/IEC\/2021\/078). Written informed consent was obtained from the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"471"}}